Clinical Trial Update: Clinical Trail to Evaluate the Efficacy and Safety of DWJ1451 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating DWJ1451 for hypertension and dyslipidemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hypertension

Drugs mentioned

• DWJ1451

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Hypertension, Dyslipidemia | Phase 3 | Status: UNKNOWN